Related Experiment Videos
[Prognostic factors in thin cutaneous malignant melanoma]
D Massi1, A Franchi, M Santucci
1Dipartimento di Patologia Umana ed Oncologia, Università degli Studi di Firenze, Viale G.B. Morgagni 85, I-50134 Firenze, Italia.
Pathologica
|January 24, 2003
Summary
Thin melanomas (< or = 1 mm) are increasingly diagnosed. While most have excellent prognoses, some thin melanomas can recur or metastasize, necessitating further prognostic factor research beyond Breslow thickness.
Area of Science:
- Dermatology
- Oncology
- Pathology
Context:
- Increasing diagnosis of thin (< or = 1 mm) cutaneous malignant melanomas.
- Prognostic uncertainty for a subset of thin melanomas despite generally favorable outcomes.
Purpose:
- Identify prognostic factors beyond Breslow thickness for thin melanomas.
- Determine the impact of histopathological parameters on melanoma progression.
Summary:
- Breslow thickness is a key prognostic factor, but not sufficient for thin melanomas.
- Clark's levels and ulceration are currently significant prognostic indicators.
- Further research is needed on regression, inflammatory infiltrate, and mitotic activity for thin melanoma prognosis.
Impact:
- Improved risk stratification for thin cutaneous malignant melanomas.
- Enhanced clinical management strategies for patients with thin melanomas.
- Potential for earlier detection of aggressive subtypes, improving patient outcomes.